PureTech Health (LON:PRTC) Shares Cross Below Fifty Day Moving Average – Should You Sell?

PureTech Health plc (LON:PRTC)’s stock price passed below its fifty day moving average during trading on Monday . The stock has a fifty day moving average of GBX 140.42 ($1.81) and traded as low as GBX 128.20 ($1.66). PureTech Health shares last traded at GBX 131 ($1.69), with a volume of 186,057 shares.

Analyst Ratings Changes

Separately, Jefferies Financial Group reiterated a “buy” rating and issued a GBX 455 ($5.88) price objective on shares of PureTech Health in a report on Monday, December 16th.

PureTech Health Stock Up 1.4 %

The business’s 50-day moving average is GBX 140.42 and its two-hundred day moving average is GBX 150.31. The firm has a market capitalization of £393.50 million, a price-to-earnings ratio of -5.37 and a beta of 1.02. The company has a debt-to-equity ratio of 45.82, a quick ratio of 2.51 and a current ratio of 3.68.

PureTech Health Company Profile

PureTech Health plc, a clinical-stage biopharma company, focuses on developing medicines for diseases caused by dysfunctions in the nervous, gastrointestinal, and immune systems. The company is developing a microbiome immune system drug-discovery platform and drug candidates for immune-mediated diseases; and products to induce weight loss and enhance glycaemic control through an orally administered capsule.